Delivery Order SPE2DR25D1100-SPE2DR26FCS6T
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,459.86 by the Defense Logistics Agency on September 15, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). The contract is classified as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the company's location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $36,921.15 by the Defense Logistics Agency (DLA) on November 12, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $12,977.16 to supply Zepbound 15 mg/0.5 mL pen injections, with an ultimate completion date of December 1, 2025. This competitive award with firm fixed pricing reflects the contractor's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,054.70 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award, and requires completion by August 26, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,644.60 by the Defense Logistics Agency on September 23, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $3,431.61 on August 21, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's larger relationship...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on December 3, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injections with a ceiling value of $3,623.56. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The contract is performed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,040.82 by the Defense Logistics Agency (DLA) for Zepbound 5 mg/0.5 ml pens. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitive award issued against AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $35,435.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 9, 2025, for Zepbound 7.5 mg/0.5 mL pens. The contract, which carries an ultimate completion date of September 10, 2025, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $12,150.18 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on November 17, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of November 18, 2025. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS6TDelivery Order
AmerisourceBergen Drug Corp was awarded a $1,107.42 firm fixed price delivery order on December 3, 2025, by the Defense Logistics Agency (DLA) for Zepbound 12.5 mg/0.5 ml pen injections. This is a non-set-aside competitive award with an ultimate completion date of December 4, 2025 and place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio with DLA demonstrates its capability to fulfill competitive federal procurement requirements across multiple therapeutic domains, with delivery orders spanning from small-value transactions to substantial orders exceeding $45,000, all utilizing firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/2/25 |